Hormone replacement therapy in perimenopausal women and 2-year change of carotid intima-media thickness

Maturitas

Volumn 32, Issue 3, 1999, Pages 195-204

  De Kleijn, Miriam J J ^a   Bots, Michiel L ^a,b   Bak, Annette A A ^a   Westendorp, Iris C D ^b   Planellas, Juan ^c   Coelingh Bennink, Herjan J T ^c   Witteman, Jacqueline C M ^b   Grobbee, Diederick E ^a,b  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c NV ORGANON   (Netherlands)

Author keywords

Combined 17 estradiol and desogestrel; Common carotid intima media thickness; Desogestrel; Equine estrogens; Norgestrel

Indexed keywords

CONJUGATED ESTROGEN; DESOGESTREL; ESTRADIOL; NORGESTREL; PLACEBO;

ADULT; ARTERY INTIMA PROLIFERATION; ARTICLE; CAROTID ARTERY; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MAJOR CLINICAL STUDY; MENOPAUSE; ORAL DRUG ADMINISTRATION; RANDOMIZED CONTROLLED TRIAL; ULTRASOUND;

ADULT; CAROTID ARTERY, COMMON; DESOGESTREL; DOUBLE-BLIND METHOD; ESTRADIOL; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; MIDDLE AGED; PREMENOPAUSE; TIME FACTORS; TUNICA INTIMA; TUNICA MEDIA;

EQUIDAE;

EID: 0032785393     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(99)00035-3     Document Type: Article

References (31)

1. Schouw van der Y.T., Graaf van der Y., Steyerberg E.W., Eijkemans M.J.C., Banga J.D. Age at menopause as a risk factor for cardiovascular mortality. Lancet. 347:1996;714-718.
2. Stampfer M.J., Colditz G.A. Oestrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence. Prev Med. 20:1991;47-63.
3. Grady D., Rubin S.M., Petitti D.B., Fox C.S., Black D., Ettinger B. Hormone therapy to prevent disease and prolong life in postmenopausal women. Ann Intern Med. 117:1992;1016-1037.
4. Manolio T.A., Furberg C.D., Shemanski L. et al. Associations of postmenopausal oestrogen use with cardiovascular disease and its risk factors in older women. Circulation. 88([Part 1]):1993;2163-2171.
5. McCrohon J.A., Adams M.R., McCredie R.J. et al. Hormone replacement therapy is associated with improved arterial physiology in healthy postmenopausal women. Clin Endocrinol. 45:1996;435-441.
6. Lieberman E.H., Gerhard M.D., Uehata A. et al. Oestrogen improves endothelium-dependent, flow-mediated vasodilatation in postmenopausal women. Ann Intern Med. 121:1994;936-941.
7. Adams M.R., Kaplan J.R., Manuck S.B. Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone. Arteriosclerosis. 10:1990;1051-1057.
8. Espeland M.A., Applegate W., Furberg C.D. et al. Oestrogen replacement therapy and progression of intimal-thickness in the carotid arteries of postmenopausal women. Am J Epidemiol. 142:1995;1011-1019.
9. Jonas H.A., Kronmal R.A., Psaty B.M. et al. Current oestrogen-progestin and oestrogen replacement therapy in elderly women: association with carotid atherosclerosis. Ann Epidemiol. 6:1996;314-323.
10. Groeneveld F.P., Bareman F.P., Barentsen R., Dokter H.J., Drogendijk A.C., Hoes A.W. Determinants of first prescription of hormonal replacement therapy. A follow-up study among 1689 women aged 45-60. Maturitas. 20:1994;81-89.
11. Heiss G., Sharett A.R., Barnes R., Chambless L.E., Szklo M., Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 134:1991;250-256.
12. Psaty B.M., Furberg C.D., Kuller L.H., Borhani N.O., Rautaharju P.M., O'Leary D.H. Isolated systolic hypertension and subclinical cardiovascular disease in the elderly. Initial findings from the Cardiovascular Health Study. J Am Med Assoc. 268:1992;1287-1291.
13. Bonithon-Kopp C., Scarabin P., Taquet A., Touboul P., Malmejac A., Guize L. Risk factors for early carotid atherosclerosis in middle-aged French women. Arterioscler Thromb. 11:1991;966-972.
14. Bots M.L., Hofman A., Grobbee D.E. Common carotid intima-media thickness and lower extremity arterial atherosclerosis. The Rotterdam Study. Arterioscler Thromb. 14:1994;1885-1891.
15. Salonen R., Salonen J.T. Determinants of carotid intima-media thickness: a population-based ultrasonography study in eastern Finnish men. J Intern Med. 229:1991;225-231.
16. Bots M.L., Witteman J.C.M., Grobbee D.E. Carotid intima-media wall thickness in elderly women with and without atherosclerosis of the abdominal aorta. Atherosclerosis. 102:1993;99-105.
17. Bots M.L., Hofman A., de Bruijn A.M., de Jong P.T.V.M., Grobbee D.E. Isolated systolic hypertension and vessel wall thickness of the carotid artery: The Rotterdam Elderly Study. Arterioscler Thromb. 13:1993;64-69.
18. Salonen J.T., Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 11:1991;1245-1249.
19. Bots M.L., Hoes A.W., Koudstaal P.J., Hofman A., Grobbee D.E. Common carotid intima-media thickness and risk of stroke and myocardial infarction. The Rotterdam Study. Circulation. 96:1997;1432-1437.
20. Grobbee D.E., Bots M.L. Carotid intima-media thickness as an indicator of generalized atherosclerosis. J Intern Med. 236:1994;567-573.
21. Nabulsi A.A., Folsom A.R., Szklo M., White A., Higgins M., Heiss G. No association of menopause and hormone replacement therapy with carotid artery intima-media thickness. Circulation. 94:1996;1857-1863.
22. McGrath B.P., Liang Y., Teede H., Shiel L.M., Cameron J.D., Dart A. Age-related deterioration in arterial structure and function in postmenopausal women. Impact of hormonal replacement therapy. Arterioscler Thromb Vasc Biol. 18:1998;1149-1156.
23. Friedewald W.T., Levy R.I., Fredrickson D.S. Estimation of concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem. 18:1972;499-502.
24. Wendelhag I., Gustavsson T., Suurkula M., Berglund G., Wikstrand J. Ultrasound measurement of wall thickness in the carotid artery: fundamental principles, and description of a computerized analyzing system. Clin Physiol. 11:1991;565-577.
25. Bots M.L., Mulder P.G.H., Hofman A., VanEs G.A., Grobbee D.E. Reproducibility of carotid vessel wall thickness measurements. The Rotterdam Study. J Clin Epidemiol. 47:1994;921-930.
26. Effects of oestrogen or oestrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal oestrogen/progestin interventions (PEPI) trial. J Am Med Assoc. 273:1995;199-208.
27. Moerman C.J., Witteman J.C.M., Collette H.J.A. et al. Hormone supplements: a useful tool in the prevention of coronary artery disease in postmenopausal women? Eur J Cardiol. 17:1996;658-666.
28. Beresford S.A.A., Weiss N.S., Voigt L.F., McKnight B. Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women. Lancet. 349:1997;458-461.
29. Hulley S., Grady D., Bush T. et al. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. J Am Med Assoc. 280:1998;605-613.
30. Rajkumar C., Kingwell B.A., Cameron J.D. et al. Hormonal therapy increases arterial compliance in postmenopausal women. J Am Coll Cardiol. 30:1997;350-356.
31. New G., Timmins K.L., Duffy S.J. et al. Long-term estrogen therapy improves vascular function in male to female transsexuals. J Am Coll Cardiol. 29:1997;1437-1444.